Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/07/2002WO2001048187A9 A molecular switch for regulating mammalian gene expression
11/07/2002WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002WO2001046406A9 New qtl's on chromosomes x, 2, 6 and 7 of pigs
11/07/2002WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants
11/07/2002WO2001042784A9 Methods for screening compounds active on neurons
11/07/2002WO2001029240A9 Regeneration
11/07/2002WO2001021220A9 Bioprosthetic heart valves
11/07/2002US20020166145 Coffee mannanase
11/07/2002US20020166140 Mutated barnase gene and plant transformed by the same
11/07/2002US20020166134 Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same
11/07/2002US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002US20020166130 Expression of active human factor IX in mammary tissue of transgenic animals
11/07/2002US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002US20020165383 Tenebrio antifreeze proteins
11/07/2002US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002US20020165374 Secreted protein HFEAF41
11/07/2002US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002US20020165177 Modified factor VIII cDNA
11/07/2002US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription
11/07/2002US20020165154 Lipoprotein-regulating medicaments
11/07/2002US20020165143 Identification and isolation of novel DNA
11/07/2002US20020165141 Methods for promoting dendritic cell proliferation or differentiation
11/07/2002US20020165137 Diagnosing, treating, preventing and/or prognosing disorders related to these polypeptides
11/07/2002US20020165131 Histidine-rich glycoprotein
11/07/2002US20020165114 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
11/07/2002US20020164802 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
11/07/2002US20020164799 Expression vector coding proteins for use in the treatment of cancer
11/07/2002US20020164797 Stable in vitro culture of plant cells and phytopathogens for use in the generation of preferential compounds
11/07/2002US20020164796 Tissue section for use in the propagation, culture and grafting of animal
11/07/2002US20020164794 Pluripotent somatic stem cells for use in regenerative medicine
11/07/2002US20020164793 Generating skin cells; obtain skin cells, keratinocytes and nutrient broths, culture cell, recover cells
11/07/2002US20020164792 Identification of human cell lines for the production of human proteins by endogenous gene activation
11/07/2002US20020164791 Primitive neural stem cells and method for differentiation of stem cells to neural cells
11/07/2002US20020164790 Activating growth of lung alveolar surface; obtain lung stem cells, graft into defective lung, monitor propagation of lung alveolar surface
11/07/2002US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002US20020164782 Adenovirus vectors for gene therapy
11/07/2002US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans
11/07/2002US20020164770 DNA transfection system for the generation of infectious influenza virus
11/07/2002US20020164768 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of thrombosis and vascular system disorders
11/07/2002US20020164767 DNA encoding the human serine protease C-E
11/07/2002US20020164757 Plant proteins
11/07/2002US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders
11/07/2002US20020164747 Gene cluster for ramoplanin biosynthesis
11/07/2002US20020164743 Novel cytidine deaminase
11/07/2002US20020164742 DNA encoding methymycin and pikromycin
11/07/2002US20020164738 Cell death inhibitory protein
11/07/2002US20020164735 Methods and compositions relating to a cardiac-specific nuclear regulatory factor
11/07/2002US20020164734 Human pelota homolog
11/07/2002US20020164720 Generating 2'-deoxyribonucleoside; obtain microorganism, transform with vector containing ribonucleotide reductase, express vector, incubate with substrate, recover 2'-deoxyribonucleoside
11/07/2002US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002US20020164711 Megakaryocyte differentiation factor
11/07/2002US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002US20020164690 Receptor based antagonists and methods of making and using
11/07/2002US20020164685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infectious diseases
11/07/2002US20020164683 Human sel-10 polypeptides and polynucleotides that encode them
11/07/2002US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002US20020164622 Subtle mitochondrial mutations as tumor markers
11/07/2002US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002US20020164591 Enzymatic polypeptide for use in determining biopolymer sequences
11/07/2002US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002US20020164572 Human immunodeficiency virus (hiv); azt; pfa; drug resistant viral strains; reverse transcriptase inhibitors; lipophilic phosphonoacid/nucleoside conjugates, with exceptional anti-viral activity, for use against drug-resistant hiv strains
11/07/2002US20020164399 Using enzyme mixture
11/07/2002US20020164334 Antibody-induced apoptosis
11/07/2002US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
11/07/2002US20020164314 Therapy for nervous system disorders
11/07/2002US20020164313 Therapy for muscular dystrophy
11/07/2002US20020164309 Cell culture of nervous system cells
11/07/2002US20020164308 Embryonic stem cells and neural progenitor cells derived therefrom
11/07/2002US20020164307 Replacement of damage cells
11/07/2002DE10126137C1 In vitro preparation of cells, tissues and organs, useful e.g. as wound dressing, as model or implant, by growing on resorbable matrix of hydrolyzed silane
11/07/2002DE10120505A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von Krebserkrankungen Use of stimulated peripheral blood mononuclear cells for the treatment of cancer
11/07/2002CA2715570A1 Cripto blocking antibodies and uses thereof
11/07/2002CA2454276A1 Neural progenitor cells
11/07/2002CA2448599A1 Maturation of antigen-presenting cells using activated t cells
11/07/2002CA2446079A1 Modulators of elastase inhibitor secretion
11/07/2002CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002CA2445961A1 Culture system for mouse tracheal epithelial cells
11/07/2002CA2445945A1 Modified organs and cells for xenotransplantation
11/07/2002CA2445596A1 Method for replicating the hepatitis c virus
11/07/2002CA2445593A1 Genetically modified yt cell line and use thereof
11/07/2002CA2445523A1 Composite scaffolds and methods using same for generating complex tissue grafts
11/07/2002CA2445382A1 Method for generating highly active human dendritic cells from monocytes
11/07/2002CA2445367A1 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002CA2445349A1 Anti-cd40 monoclonal antibody
1 ... 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 ... 1827